The link between inhibition of nitric oxide metabolite production and reduction of LPS induced lung injury.
Michael
M
Eisenhut
D000818:Animals; D006801:Humans; D019344:Lactic Acid / Q000378:metabolism*; D008070:Lipopolysaccharides / Q000008:administration & dosage; D055370:Lung Injury / Q000188:drug therapy / Q000378:metabolism*; D051379:Mice; D023421:Models, Animal; D009569:Nitric Oxide / Q000378:metabolism*; D011654:Pulmonary Edema / Q000188:drug therapy / Q000378:metabolism*; D020545:Respiratory Mucosa / Q000187:drug effects / Q000378:metabolism*; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism; D013150:Spirostans / Q000008:administration & dosage
D008070:Lipopolysaccharides; D013150:Spirostans; D009569:Nitric Oxide; D019344:Lactic Acid; C012541:ruscogenin; D000254:Sodium-Potassium-Exchanging ATPase